Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lun...
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
About this item
Full title
Author / Creator
Hong, Lingzhi , Lewis, Whitney E. , Nilsson, Monique , Patel, Sonia , Varghese, Susan , Rivera, Melvin J. , Du, Robyn R. , Chen, Pingjun , Kemp, Haley N. , Rinsurongkawong, Waree , Heeke, Simon , Spelman, Amy R. , Elamin, Yasir Y. , Negrao, Marcelo V. , Sepesi, Boris , Gibbons, Don L. , Lee, J. Jack , Wu, Jia , Vokes, Natalie I. , Heymach, John V. , Zhang, Jianjun and Le, Xiuning
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Background: The benefit of chemotherapy combined with immunotherapy in EGFR-mutant lung adenocarcinoma (LUAD) patients whose tumor developed resistance to EGFR tyrosine kinase inhibitors (TKIs) is not thoroughly investigated. The goal of this retrospective cohort study is to assess the clinical efficiency of immunotherapy alone or in combination wi...
Alternative Titles
Full title
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
Authors, Artists and Contributors
Author / Creator
Lewis, Whitney E.
Nilsson, Monique
Patel, Sonia
Varghese, Susan
Rivera, Melvin J.
Du, Robyn R.
Chen, Pingjun
Kemp, Haley N.
Rinsurongkawong, Waree
Heeke, Simon
Spelman, Amy R.
Elamin, Yasir Y.
Negrao, Marcelo V.
Sepesi, Boris
Gibbons, Don L.
Lee, J. Jack
Wu, Jia
Vokes, Natalie I.
Heymach, John V.
Zhang, Jianjun
Le, Xiuning
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9323840
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9323840
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers14143473
